A
Abraham D. Flaxman
Researcher at Institute for Health Metrics and Evaluation
Publications - 215
Citations - 106137
Abraham D. Flaxman is an academic researcher from Institute for Health Metrics and Evaluation. The author has contributed to research in topics: Population & Verbal autopsy. The author has an hindex of 66, co-authored 195 publications receiving 88582 citations. Previous affiliations of Abraham D. Flaxman include Microsoft & University of Queensland.
Papers
More filters
Journal ArticleDOI
What is the optimal recall period for verbal autopsies? Validation study based on repeat interviews in three populations
Peter T. Serina,Ian Riley,Ian Riley,Bernardo Hernández,Abraham D. Flaxman,Devarsetty Praveen,Veronica Tallo,Rohina Joshi,Diozele Sanvictores,Andrea Stewart,Meghan D. Mooney,Christopher J L Murray,Alan D. Lopez +12 more
TL;DR: It is substantiated the WHO recommendation that it is reasonable to collect VAs up to 1 year after death providing it is accepted that probability of a correct diagnosis is likely to decline month by month during this period.
Journal ArticleDOI
Proportional multistate lifetable modelling of preventive interventions: concepts, code and worked examples.
Tony Blakely,Robert Moss,James R. Collins,Anja Mizdrak,Ankur Singh,Natalie Carvalho,Nick Wilson,Nicholas Geard,Abraham D. Flaxman +8 more
TL;DR: A Python-based modelling framework and associated tools are introduced that facilitate the construction, calibration and analysis of PMSLT models that are well suited to future multiple country comparisons to better inform national, regional and global prioritization of preventive interventions.
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study
Louisa Degenhardt,Alize J. Ferrari,Bianca Calabria,Wayne Hall,Wayne Hall,Rosana E. Norman,Rosana E. Norman,John J. McGrath,Abraham D. Flaxman,Rebecca E. Engell,Greg Freedman,Harvey Whiteford,Harvey Whiteford,Theo Vos +13 more
TL;DR: In this paper, the authors used DisMod-MR to estimate the prevalence of cannabis dependence and its contribution to the global burden of disease and found that regular cannabis use as a risk factor for schizophrenia is not a major contributor to population-level disease burden.
Journal ArticleDOI
The potential to expand antiretroviral therapy by improving health facility efficiency: evidence from Kenya, Uganda, and Zambia
Laura Di Giorgio,Mark Moses,Nancy Fullman,Alexandra Wollum,Ruben Conner,Jane Achan,Tom Achoki,Kelsey Bannon,Roy Burstein,Emily Dansereau,Brendan DeCenso,Kristen Delwiche,Herbert C. Duber,Emmanuela Gakidou,Anne Gasasira,Annie Haakenstad,Michael Hanlon,Gloria Ikilezi,Gloria Ikilezi,Caroline Kisia,Aubrey J. Levine,Mashekwa Maboshe,Felix Masiye,Felix Masiye,Samuel H. Masters,Chrispin Mphuka,Pamela Njuguna,Thomas A. Odeny,Emelda A. Okiro,D. Allen Roberts,Christopher J L Murray,Abraham D. Flaxman +31 more
TL;DR: In this article, the authors quantified facility-level technical efficiency across countries, assessed potential determinants of efficiency, and predicted the potential for additional ART expansion, and estimated how many additional ART visits could be accommodated if facilities with low efficiency thresholds reached those levels of efficiency.
Journal ArticleDOI
A sharp threshold for a random constraint satisfaction problem
TL;DR: This paper considers random instances I of a constraint satisfaction problem generalizing k -SAT, and studies the probability of satisfiability for a random instance I formed by including every k -tuple of literals independently with probability p.